Top 50 Biotech Startup Investors in Austria in January 2026
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Austria. We rank investors based on the number of investments they made in Biotech companies from Austria. We update this investor list every month.Top 50 Biotech Startup Investors in Austria in January 2026
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Medical Device
- Seed, Pre-Seed, Series A
- Austria, France, Slovenia
Portfolio highlights
- Syntropic Medical GmbH — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more
Investment focus
- Biotechnology, Medical, Software
- Seed, Pre-Seed, Series A
- Austria, Slovenia
Portfolio highlights
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Series A
- Austria
Portfolio highlights
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Grant, Pre-Seed
- Austria, Belgium
Portfolio highlights
- HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
- Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
- Aileen Health — Medical images detect tumors. What if they helped clinicians look ahead too, for guided therapy selection? Meet the GenAI companion Cancer4D.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Funding Round, Series B
- Germany, France, Austria
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
- ASTRA Therapeutics — Astra - Therapeutics
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- Austria, United States, Germany
Portfolio highlights
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- Planted Green — Planted Green plants mixed forests to compensate for CO2 emissions.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
Entrepreneur, Angel Investor, Scientist and Inventor
Show more
Investment focus
- mHealth, Software, Biopharma
- Seed, Angel, Pre-Seed
- Austria
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
SPV
Show more
Investment focus
- Biotechnology, Health Diagnostics
- Seed
- Austria
Portfolio highlights
- Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
The Aescap funds invest in the most promising innovative listed biotech companies with exceptional growth potential
Show more
Investment focus
- Biotechnology, Pharmaceutical, Chemical
- Series A, Series B, Funding Round
- United Kingdom, Austria, Belgium
Portfolio highlights
- Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
- Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
- F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Funding Round, Series A
- United States, China, Canada
Portfolio highlights
- Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
- Petal Surgical — Petal is a surgical technology company pioneering incisionless surgery through Acoustic Sculpting, a proprietary form of boiling histotripsy. Our platform uses focused sound waves to precisely destroy harmful tissue without cuts, heat, or toxicity offering gentler alternative to traditional surgery.
- Carbon Free Energy Cloud — Carbon Credits Simplified
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Pre-Seed
- Germany, United States, United Kingdom
Portfolio highlights
- Raus — Raus is a hospitality-tech startup that offers new opportunities to take a break from big city life. Raus serves as a welcome escape from the seemingly endless demands and constant stimuli of modern life with perfectly simple cabins, close enough for a spontaneous getaway, far enough away to completely unwind.
- Ixana — Ixana operates as a wearable hardware company, that develops human-computer interfaces.
- Lyceum — Introducing the smartest way to train your models in the cloud. The electricity socket for your infrastructure needs.
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel.
Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more
Investment focus
- Information Technology, Artificial Intelligence, Software
- Pre-Seed, Seed, Series A
- Switzerland, Germany, Israel
Portfolio highlights
- Neon — With neon, you can pay, save and manage your money. Digitally, securely and with no hidden fees. Open your account online in less than 10 minutes!
- Evoralis — Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes. It is a spin-out from the University of Cambridge.
- Proofcheck — Proofcheck is a multilingual AI proofreading platform and a collaborative in-browser workspace for PDFs and epubs. Their next-generation AI workflow and collaboration tool helps content creators quickly catch costly mistakes before they reach audiences. Proofcheck is headquartered in Vienna, Wien and was founded in 2022.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Germany
Portfolio highlights
- Datamonk — AI-powered PACS migration platform that automates secure and fast transfers of medical imaging data. Migrate up to 10TB per day and use AI agents for data validation and quality assurance.
- io Health — Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare.
- Sober Sidekick — Gamified peer to peer support
Fundamental Equity Investing, since 1998
Show more
Investment focus
- Biotechnology, Machine Learning, Finance
- Funding Round, Series A, Series B
- United Kingdom, Austria, United States
Portfolio highlights
- Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- AMNIS Treasury Services — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
| Investments that move industries
Show more
Investment focus
- Software, Apps, Information Technology
- Seed, Series A, Funding Round
- Austria, Germany, United States
Portfolio highlights
- Podero — Podero energy flexibility software helps utilities steer devices, trade their flexibility on spot and balancing markets and launch new energy products.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
bmp Ventures is an innovative Venture Capital Company from Berlin.
Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Germany, United States, Austria
Portfolio highlights
- CYNiO — CYNiO is an innovative chemical startup dedicated to revolutionizing the production of isocyanates through a safe, flexible, and sustainable approach.
- NorcSi GmbH — Entwicklung von neuartigen Batterietechnologien
- byte robotics — Byte Robotics developed a springboard innovative software technology for robot program generation.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Funding Round
- Austria
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
Investing globally in technologies extending healthy lifespans
Show more
Investment focus
- Biotechnology, Health Care, Personal Health
- Seed, Convertible Note, Pre-Seed
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
- MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
We back B2B software and life-sciences companies with limitless scalability.
Show more
Investment focus
- Software, Biotechnology, Telecommunications
- Funding Round, Seed
- Austria, Germany
Portfolio highlights
- Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
- a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
We are an early stage VC for climate tech startups.
Show more
Investment focus
- Software, Energy, Renewable Energy
- Seed, Pre-Seed, Funding Round
- Germany, Switzerland, Finland
Portfolio highlights
- Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
- Milvus Advanced — Our Midas-touch alloys replicate the functional properties of platinum-group metals at a fraction of the cost.
- Zymvol Biomodeling — Physics-AI hyperrealistic enzyme discovery. ZYMVOL helps R&D managers uncover hidden opportunities and screen areas overlooked by traditional methods.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Funding Round, Pre-Seed
- United Kingdom, United States, Austria
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Grant, Seed, Pre-Seed
- Austria, United States, Belgium
Portfolio highlights
- Chatlyn — Automated, AI-enhancend guest engagement, where your clients are most comfortable.
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival
venture capital
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Series B
- Hungary, South Korea, United States
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more
Investment focus
- Software, Robotics, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, France, United Kingdom
Portfolio highlights
- Karman+ — Mining near Earth asteroids
- Alpine Eagle — The Sentinel Counter-UAS System is an air-to-air sensor & interceptor network designed to detect, classify, and intercept unmanned aerial systems (UAS)
- Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Funding Round, Series B, Series A
- United States, Germany, United Kingdom
Portfolio highlights
- Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
- Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
- Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Series B, Funding Round, Series C
- United States, Germany, Switzerland
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
- Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Show more
Investment focus
- Health Care, Biotechnology
- Seed
- Austria
Portfolio highlights
- Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
INVEST AG is the investment arm of the Raiffeisen bank group of Upper Austria and is one of Austria’s leading private equity funds, managing a volume of 180 million euros. As an evergreen fund with an indefinite term, we are able to provide long-term stability and a solid foundation for future success, which is particularly relevant for anincreasing number of medium-sized companies facing a growing need for equity.The benefits of private equity:No personal liability of the partners
No securities to weigh you down
Greater risk capacity
Since its founding in 1994, INVEST AG has already invested equity and mezzanine capital in more than 140 companies in a wide variety of sectors. Currently, 26 companies in Austria and the south of Germany trust in our expertise and benefit from our support in operational, commercial, and strategic matters.Whatever situation you find yourself in as a company and whatever problem you are seeking a custom-made solution to, be assured that you will always find us to be a highly experienced and reliable partner.
Show more
Investment focus
- Security, Hospitality, Food and Beverage
- Seed, Private Equity
- Austria, United States
Portfolio highlights
- NEOH USA — NEOH USA is a fast growing new food brand from Kirkland, WA and the leader in Crossbars. It satisfies your sweet tooth without the guilt. Crossbars taste as great as a candy bars but are protein bars.
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
- RadarServices — RadarServices is the European market leader for proactive IT security monitoring and IT risk detection as managed services. The services uniquely combine automated detection of security relevant issues and risks with the analysis and assessment done by experts. Data never leaves the clients‘ premises.
New generation venture capital investing into combinatorial technologies
Show more
Investment focus
- Artificial Intelligence, Information Technology, Machine Learning
- Pre-Seed, Seed
- Czech Republic, United States, United Kingdom
Portfolio highlights
- Wultra — Wultra helps the leading banks and fintech companies to secure their digital systems and bring trust to the customer journeys. Our security-related software technologies cover the whole digital banking application stack, be it on the web or mobile platforms.
- Openvibe — Interact With Anyone On The Open Internet. All Decentralised Social Networks, Single Timeline.
- Edmund — Edmund is an enterprise level system that interconnects all manufacturing technologies, providing a comprehensive view of entire factory.
We are i&i Biotech Fund, partners of outstanding founders on their path to global success. We invest in innovative early stage Life Sciences startups.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A
- Czech Republic, India, Spain
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Lea-Sophie Cramer (born April 16, 1987 in Berlin , Germany ) is a German entrepreneur . She founded in 2013 together with Sebastian Pollok, the online retailer and manufacturer of Sextoys, Amorelie, whose CEO she has been since. The business magazine Forbes named her in 2016 as one of the "30 under 30 Europe", the leading youngentrepreneurs in Europe. [1]
Show more
Investment focus
- Food and Beverage, FinTech, Sustainability
- Seed, Pre-Seed, Angel
- Germany, Austria
Portfolio highlights
- eco.mio — eco.mio enables companies to reach their climate targets while realizing significant savings: Incentivize employees to travel consciously with eco mio's end-to-end integrated software solution.
- Nala Earth — Nala empowers companies to measure, manage and report their impact and dependency on nature - compliant with regulation.
- HELLO INSIDE — Glukose-Monitoring zeigt dir, wie Mahlzeiten, Stress und Schlaf deine Energie, dein Gewicht und deine Hormone beeinflussen. 12.000+ Frauen vertrauen Hello Inside. 30-Tage-Program
Financing for startups in Styria
Show more
Investment focus
- Software, Audio, Travel
- Seed, Grant, Funding Round
- Austria
Portfolio highlights
- teamazing — Unlock your team's full potential! Tailored workshops, tools & events for continuous team development. Analyze, build, and grow with teamazing!
- Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
- Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.
Investing in the ReGeneration
Show more
Investment focus
- Agriculture, Biotechnology, Farming
- Seed, Series A, Series B
- United States, Austria, United Kingdom
Portfolio highlights
- Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
- PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
- Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Aiolos Bio — Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by anaccomplished team with decades of drug development experience and leadership in the biotech industry.
- Tessellate BIO — Tessellate BIO is redefining synthetic lethality in cancer beyond homologous recombination deficiency, turning cancer patients into cancer surivivors.
- Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Series C, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Crédit Agricole CIB specialises in the businesses of capital markets and investment and corporate banking.
Show more
Investment focus
- Energy, Solar, Renewable Energy
- Debt Financing, Series A, Post-IPO Debt
- France, United States, United Kingdom
Portfolio highlights
- CoreWeave — CoreWeave provides flexible compute services and products to empower innovators. The company provides GPU accelerated compute solutions to the CGI and machine learning industries. Backed by quality hardware and systems management infrastructure, CoreWeave is built to help clients scale and adapt to evolving compute requirements at industry leadingeconomics.
- NEOM — THE LINE: THE FUTURE OF URBAN LIVING
- Tipico Group — Tipico is the market provider of sports betting in Germany, with a strong position across other European markets as well. The company operates an innovative, digital multichannel offering with leading online and mobile portals, as well as more than 1,000 betting shops. As a premium brand, Tipico is able to offer a large range of bets whilecontinuing to uphold the highest standards in customer service and consumer protection. Tipico currently has more than 5,000 employees and operates in five countries.
Valnon Holding is an investment firm that invest in early-stage companies.
Show more
Investment focus
- Biotechnology, Chemical Engineering
- Seed
- Austria
Portfolio highlights
- Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- BetterOmics — The Omics AI Cloud
- l`école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Series B
- Germany, France, Sweden
Portfolio highlights
- Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
- simplyblock — High-performance storage software designed for databases with low latency, high scalability and high IOPS. NVMe-optimized. Alternative SAN or EBS. Scalable Block Storage software. Simplyblock | Simply Block | Simplyblock Block Storage
- Go Autonomous — Unlock advantages of Autonomous Commerce and experience heightened efficiency, reduced costs, and seamlessly interaction for both buyers and sellers.
Axilium Holding
Show more
Investment focus
- Life Science, Biotechnology, Semiconductor
- Seed
- Austria
Portfolio highlights
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Kale United offers a portfolio of over 75+ plant-based game changers
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Pre-Seed, Funding Round
- United Kingdom, Sweden, India
Portfolio highlights
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
- Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more
Investment focus
- Electronics, Software, Medical Device
- Funding Round, Seed, Series A
- Germany, Austria
Portfolio highlights
- Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
- Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
- Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
GLS Ventures
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series B, Funding Round
- Austria
Portfolio highlights
- Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
The European Venture Fund that backs gender-diverse founder teams.
Show more
Investment focus
- AgTech, EdTech, Software
- Pre-Seed, Seed
- Austria, United Kingdom
Portfolio highlights
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
- KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
- Willow Stories — Preserve your legacy and honor loved ones by creating lasting memorials.
A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Corporate Round, Post-IPO Debt, Series A
- United States, Austria
Portfolio highlights
- Agenus — Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
- invIOs — invIOs is a private biotechnology company that specializes in the discovery and development of next-generation cancer therapies that empower and educate the immune system to fight cancer.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures
Show more
Investment focus
- Software, Information Technology, Apps
- Seed, Series A, Funding Round
- Germany, Austria, Estonia
Portfolio highlights
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Pilzling — Bio-Pilze direkt aus deiner Stadt.
- LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.
IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.
Show more
Investment focus
- Sensor, Medical, Wireless
- Series B, Funding Round
- Austria
Portfolio highlights
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Web3
Organic Food
Art
Big Data
Wellness
Android
Video Games
Digital Media
Manufacturing
Publishing
Construction
Sports
Franchise
B2B
eSports
Mobile
Food and Beverage
Enterprise Software
Music
Email
Payments
Social Media
Social Network
Real Estate
Medical
Legal
Finance
Local
Education
Internet
Biotechnology
Travel
Financial Services
Fitness
Recruiting
Hospitality
Mobile Advertising
Platforms
Cannabis
Retail
Automotive
Social
Wine And Spirits
Infrastructure
Medical Device
Crowdfunding
Beauty
CleanTech
Mobile Apps
Transportation
Photography
InsurTech
Enterprise
LGBT
Film
Oil and Gas
Fashion
Life Science
Theatre
SaaS
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Agriculture (agtech)
Cryptocurrency
Machine Learning
Media (entertainment)
Blockchain
Facebook
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Armenia
Saudi Arabia
Ghana
Egypt
Oceania
Belarus
Hungary
Africa
Finland
France
Croatia
LATAM
Gibraltar
Barbados
Asia
Georgia
Greece
Brazil
Czech Republic
Liechtenstein
Faroe Islands
Costa Rica
Panama
Hong Kong
Bahrain
Myanmar
Belgium
Lithuania
Denmark
Bermuda
Estonia
Malaysia
Algeria
Ecuador
Bulgaria
Peru
Belize
Chile
Liberia
Ethiopia
Togo
Rwanda
Jersey
Lebanon
Slovenia
Norway
Poland
Uganda
San Marino
Sweden
Mexico
Serbia
Sierra Leone
Thailand
Tanzania
Italy
Uzbekistan
Zambia
Turkey
Uruguay
Mali
Philippines
Tajikistan
Russian Federation
Portugal
El Salvador
Israel
Puerto Rico
Senegal
Kuwait
Zimbabwe
Tunisia
Venezuela
Mauritius
Ukraine
Taiwan
Malta
Dominican Republic
Morocco
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Nicaragua
Namibia
United Arab Emirates
Jamaica
Honduras
Luxembourg
Isle of Man
Bolivia
Pakistan
Albania
Romania
Jordan
Grenada
Argentina
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Cyprus
Oman
Latvia
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
Investors in Austria by industry
Transportation
Music
Cryptocurrency
Education
Finance
Food and Beverage
Real Estate
Organic Food
Medical
Internet
Manufacturing
Wellness
Digital Media
Blockchain
Local
Mobile
Software
Android
Enterprise Software
Sports
eSports
Fitness
Automotive
Travel
Hospitality
InsurTech
Platforms
Recruiting
FinTech
Biotechnology
Consumer
Health Care
Energy
EdTech
Sustainability
Climate
Impact
Marketplace
Proptech
SaaS
Artificial intelligence
Hardware
Mobile Apps
Gaming
B2B
Web3
Sporting Goods
Life Science
Biotech
Publishing
Financial Services
Renewable Energy
Enterprise
Medical Device
Big Data
Social Impact
Media (entertainment)
Social Media
Art
Agriculture (agtech)
Machine Learning
Construction
Community
Retail
CleanTech
Payments